Embedded Files
Company Name
Link Therapeutics Inc.
Business Description
Development of therapeutic approaches targeting autoantibodies and discovery of pathogenic autoantibodies.
Head Office
Innovation Hub Kyoto 416, 46-29 Yoshida-Shimoadachi-cho, Sakyo-ku, Kyoto, 606-8304, Japan
Board of Directors
Representative Director & CEO Toru Kawamura, PhD
(Link Therapeutics Inc.)
Director Yoshiko Abe, PhD, MBA
(Link Therapeutics Inc.)
Director Masahiro Shiokawa, MD, PhD
(Dept. of Gastroenterology and
Hepatology, Kyoto University Graduate
School of Medicine)
Director Hiroyuki Ueno
(Kyoto University Innovation Capital
Co., Ltd.)
Director Koji Abe
(Itochu Technology Ventures)
Director Mikihiko Shinozaki
(Mitsubishi UFJ Capital Co., Ltd.)
Corporate Auditor Takeshi Osawa, Attorney-at-Law
(CHUO SOGO Legal Professional
Corporation)
Scientific Advisory Committee
Tsutomu Chiba, MD, PhD
(Professor Emeritus, Kyoto University; Specially Appointed President, Kansai Electric Power Hospital)
Norifumi Hibi, MD, PhD
(Professor Emeritus, Keio University; Special Advisor, Center for Advanced IBD Research and Treatment, Kitasato University Kitasato Institute Hospital)
Established
October 4, 2022
Founders
Yoshiko Abe
Masahiro Shiokawa
Takeshi Kuwada
Established with support from Kyoto University Innovation Capital Co., Ltd.
Report abuse